Dick Menzies Selected Research

Isoniazid (Ftivazide)

4/2022	Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria.
1/2022	Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort study.
11/2021	Safety and Efficacy of Rifampin or Isoniazid Among People With Mycobacterium tuberculosis Infection and Living With Human Immunodeficiency Virus or Other Health Conditions: Post Hoc Analysis of 2 Randomized Trials.
1/2021	Evidence-based Definition for Extensively Drug-Resistant Tuberculosis.
1/2020	Estimating treatment importance in multidrug-resistant tuberculosis using Targeted Learning: An observational individual patient data network meta-analysis.
1/2020	Treatment with isoniazid or rifampin for latent tuberculosis infection: population-based study of hepatotoxicity, completion and costs.
1/2020	Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials.
1/2020	Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020.
1/2020	Health System Costs of Treating Latent Tuberculosis Infection With Four Months of Rifampin Versus Nine Months of Isoniazid in Different Settings.
1/2019	The impact of improved detection and treatment of isoniazid resistant tuberculosis on prevalence of multi-drug resistant tuberculosis: A modelling study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dick Menzies Research Topics

Disease

66	Tuberculosis (Tuberculoses) 04/2022 - 07/2003
31	Latent Tuberculosis 05/2022 - 08/2004
27	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 04/2022 - 07/2008
19	Infections 04/2022 - 03/2005
7	HIV Infections (HIV Infection) 01/2021 - 06/2007
7	Pulmonary Tuberculosis 12/2019 - 06/2007
6	Extensively Drug-Resistant Tuberculosis 04/2022 - 07/2013
3	COVID-19 01/2022 - 01/2020
2	Hepatitis 11/2021 - 11/2008
2	Renal Insufficiency (Renal Failure) 11/2021 - 07/2004
2	Exanthema (Rash) 01/2020 - 06/2003
2	Cough 11/2014 - 07/2003
2	Drug-Related Side Effects and Adverse Reactions 07/2014 - 09/2013
2	Pleural Tuberculosis 11/2007 - 10/2007
2	Lymph Node Tuberculosis (Scrofula) 11/2007 - 10/2007
2	Respiratory Insufficiency (Respiratory Failure) 01/2006 - 09/2003
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2006 - 09/2003
1	Mitochondrial Diseases (Mitochondrial Disease) 04/2022
1	Common Cold 01/2022
1	Diabetes Mellitus 11/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Blister (Bulla) 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Neoplasms (Cancer) 01/2017
1	Necrosis 12/2015
1	Silicosis 12/2015
1	Chronic Kidney Failure (Chronic Renal Failure) 09/2015
1	Malnutrition (Nutritional Deficiencies) 05/2014
1	Blindness (Hysterical Blindness) 02/2014
1	Asthma (Bronchial Asthma) 07/2012
1	Disease Progression 01/2012
1	Bronchopulmonary Dysplasia 08/2011
1	Premature Birth (Birth, Premature) 08/2011
1	Multiple Organ Failure (MODS) 10/2010

Drug/Important Bio-Agent (IBA)

31	Rifampin (Rifampicin)FDA LinkGeneric 05/2022 - 08/2004
29	Isoniazid (Ftivazide)FDA LinkGeneric 04/2022 - 08/2004
22	Pharmaceutical PreparationsIBA 04/2022 - 07/2008
15	Tuberculin (PPD)IBA 10/2020 - 11/2003
13	Interferon-gamma (Interferon, gamma)IBA 10/2020 - 08/2006
5	bedaquiline (R207910)IBA 04/2022 - 12/2013
5	AcidsIBA 01/2022 - 09/2003
5	Anti-Bacterial Agents (Antibiotics)IBA 10/2021 - 11/2003
5	FluoroquinolonesIBA 01/2021 - 07/2013
4	Linezolid (Zyvox)FDA Link 04/2022 - 01/2018
4	GoldIBA 01/2021 - 01/2013
4	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 01/2021 - 01/2021
3	AntigensIBA 10/2020 - 10/2005
3	Ethambutol (Myambutol)FDA LinkGeneric 01/2018 - 02/2014
3	Pyrazinamide FDA LinkGeneric 01/2018 - 06/2003
3	Biomarkers (Surrogate Marker)IBA 08/2013 - 05/2010
3	Immunoglobulin G (IgG)IBA 11/2007 - 06/2007
2	Carbapenems (Carbapenem Antibiotics)IBA 01/2022 - 01/2018
2	Anti-Infective Agents (Microbicides)IBA 01/2022 - 12/2019
2	Antitubercular AgentsIBA 01/2020 - 01/2018
2	insulin receptor-related receptor (IRR)IBA 01/2017 - 01/2012
2	VaccinesIBA 07/2014 - 01/2011
2	InterferonsIBA 02/2013 - 01/2012
2	RifamycinsIBA 10/2012 - 05/2010
1	Cycloserine (Seromycin)FDA Link 01/2022
1	terizidoneIBA 01/2022
1	OPC-67683IBA 01/2022
1	Aminosalicylic Acid (Rezipas)FDA Link 01/2022
1	Capreomycin (Capastat)FDA Link 12/2021
1	AminoglycosidesIBA 12/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 11/2021
1	cyclo(Arg-Pro) (CI 4)IBA 01/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2020
1	N-nitrosothiazolidine-4-carboxylic acid (NTCA)IBA 01/2020
1	Levofloxacin (Levaquin)FDA Link 01/2020
1	Streptomycin (Streptomycin Sulfate)FDA Link 01/2018
1	Clofazimine (Lamprene)FDA Link 01/2018
1	BCG Vaccine FDA Link 01/2017
1	CarbohydratesIBA 08/2015
1	VitaminsIBA 08/2015
1	Complement System Proteins (Complement)IBA 05/2014
1	LipidsIBA 08/2013
1	SmokeIBA 01/2012
1	rifapentine (Priftin)FDA Link 12/2011
1	Benzophenoneidum (Auramine O)IBA 05/2011
1	SolutionsIBA 10/2010
1	AgarIBA 10/2010

Therapy/Procedure

29	Therapeutics 01/2021 - 11/2003
4	Injections 01/2022 - 07/2013
3	Mechanical Ventilators (Ventilator) 01/2022 - 07/2003
3	Duration of Therapy 11/2021 - 07/2013
2	Contraindications 01/2020 - 11/2008
2	Art Therapy 01/2020 - 10/2012
1	Aftercare (After-Treatment) 01/2022
1	N95 Respirators 01/2022
1	Home Nursing (Nursing, Home) 01/2020
1	Retention in Care 01/2019
1	Fecal Microbiota Transplantation 01/2019
1	Drug Therapy (Chemotherapy) 03/2017
1	Pneumonectomy (Lung Volume Reduction) 04/2016
1	Transplantation 12/2015
1	Renal Dialysis (Hemodialysis) 09/2015
1	Peritoneal Dialysis 09/2015
1	Patient Readmission 07/2012
1	Chemoprevention 09/2011
1	Length of Stay 08/2011